| Stress-triggered phase separation is an adaptive, evolutionarily tuned response JA Riback, CD Katanski, JL Kear-Scott, EV Pilipenko, AE Rojek, ... Cell 168 (6), 1028-1040. e19, 2017 | 850 | 2017 |
| Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress EWJ Wallace, JL Kear-Scott, EV Pilipenko, MH Schwartz, PR Laskowski, ... Cell 162 (6), 1286-1298, 2015 | 519 | 2015 |
| Differences in narrative language in evaluations of medical students by gender and under-represented minority status AE Rojek, R Khanna, JWL Yim, R Gardner, S Lisker, KE Hauer, C Lucey, ... Journal of general internal medicine 34 (5), 684-691, 2019 | 201 | 2019 |
| Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ... Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022 | 82 | 2022 |
| Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma JK Jasielec, T Kubicki, N Raje, R Vij, D Reece, J Berdeja, BA Derman, ... Blood, The Journal of the American Society of Hematology 136 (22), 2513-2523, 2020 | 68 | 2020 |
| Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults AA Patel, J Thomas, AE Rojek, W Stock Current Treatment Options in Oncology 21, 1-21, 2020 | 32 | 2020 |
| Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy AA Patel, AE Rojek, MW Drazer, H Weiner, LA Godley, MM Le Beau, ... Blood Advances 5 (20), 4140-4148, 2021 | 21 | 2021 |
| Evolution of therapy for limited stage diffuse large B-cell lymphoma AE Rojek, SM Smith Blood Cancer Journal 12 (2), 33, 2022 | 17 | 2022 |
| CNS prophylaxis during front-line therapy in aggressive non-Hodgkin lymphomas: real-world outcomes and practice patterns from 19 US academic institutions VM Orellana-Noia, DR Reed, JM Sen, C Barlow, MK Malecek, BS Kahl, ... Blood 136, 27-28, 2020 | 16 | 2020 |
| Optimizing synchrotron microCT for high-throughput phenotyping of zebrafish PJ La Rivière, D Clark, A Rojek, P Vargas, X Xiao, F DeCarlo, ... Developments in X-Ray Tomography VII 7804, 186-193, 2010 | 9 | 2010 |
| Optimization of metabolic tumor volume as a prognostic marker in CAR T-cell therapy for aggressive large B-cell NHL AE Rojek, JP Kline, N Feinberg, DE Appelbaum, Y Pu, BA Derman, ... Clinical Lymphoma Myeloma and Leukemia 24 (2), 83-93, 2024 | 5 | 2024 |
| Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: a multicenter analysis A Alsouqi, G Ahmed, J Wang, G Cassanello, A Szabo, AE Rojek, ... American journal of hematology 99 (8), 1624-1627, 2024 | 3 | 2024 |
| Residency Training in the COVID-19 Pandemic—Addressing the Need for Systems-Based Education AE Rojek, PT Schiller JAMA Health Forum 3 (9), e223023-e223023, 2022 | 3 | 2022 |
| Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms A Kaur, AE Rojek, E Symes, MT Nawas, AA Patel, JL Patel, P Sojitra, ... Blood Cancer Journal 14 (1), 99, 2024 | 2 | 2024 |
| CAR T-cell Therapy in Mantle Cell Lymphoma with Secondary CNS Involvement-a multicenter experience. G Ahmed, A Alsouqi, A Szabo, L Samples, M Shadman, FT Awan, ... Blood Advances, bloodadvances. 2023012255, 2024 | 2 | 2024 |
| Chimeric antigen receptor T-cell (CAR-T) therapy in secondary central nervous system large B-cell lymphoma (SCNSL): a multicenter retrospective analysis G Ahmed, A Alsouqi, A Szabo, AE Rojek, PA Riedell, FT Awan, L Samples, ... Blood 142, 3088, 2023 | 2 | 2023 |
| tRNA expression and tRFs in multiple myeloma: Progression from monoclonal gammopathies to relapsed/refractory disease AE Rojek, CD Katanski, A Stefka, BA Derman, A Jakubowiak, T Pan Cancer Research 81 (13_Supplement), 2394-2394, 2021 | 2 | 2021 |
| Real‐world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia AE Rojek, BJ McCormick, J Cwykiel, O Odetola, Y Abaza, N Nai, ... EJhaem 5 (4), 728-737, 2024 | 1 | 2024 |
| Treatment Patterns Among Patients with Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia after Intensive Induction Chemotherapy AE Rojek, BJ McCormick, J Cwykiel, O Odetola, Y Abaza, R Achar, ... Blood 142, 1484, 2023 | 1 | 2023 |
| Residents as Innovators on COVID-19 Respiratory Isolation Units AE Rojek, PT Schiller Academic Medicine 97 (7), 946-947, 2022 | 1 | 2022 |
